Patents by Inventor Asumi KANDA

Asumi KANDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADJUVANT BASED ON PEPTIDE NUCLEIC ACID
    Publication number: 20230330221
    Abstract: Provided are an adjuvant useful for preparing a vaccine having high efficacy and high safety, and a vaccine composition comprising the adjuvant. The adjuvant comprises a peptide nucleic acid to which a cell penetrating peptide is bound.
    Type: Application
    Filed: June 5, 2020
    Publication date: October 19, 2023
    Applicant: DENKA COMPANY LIMITED
    Inventors: Ryotaro MITSUMATA, Asumi KANDA
  • SEASONAL INFLUENZA VACCINE CAPABLE OF INDUCING VIRUS-SPECIFIC ANTIBODY INTO NASAL CAVITY
    Publication number: 20220331419
    Abstract: Provided is a seasonal influenza vaccine having a higher efficacy than a split vaccine. A seasonal influenza vaccine which induces virus-specific antibodies in the nasal mucosa, comprises inactivated whole influenza virus particles as an active ingredient, and is to be administered intradermally at dose per administration of 15 ?g HA or more per strain as antigen.
    Type: Application
    Filed: September 2, 2020
    Publication date: October 20, 2022
    Applicant: DENKA COMPANY LIMITED
    Inventors: Ryotaro MITSUMATA, Asumi KANDA, Nagisa NAKATA, Shigetaka MIMORI